Tenet Healthcare (THC) Stock Forecast & Price Target
$21.22B
Market Cap
10.31
P/E
12.43
Forward P/E
53
Score
THC price $263.56 -4.93 -1.84%
Stocklytics score rationale: value 60, quality 39, growth 59.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 19621000000 | 19179000000 | 18313000000 | 18479000000 | 17640000000 | 19485000000 | 19174000000 | 20548000000 | 20665000000 | 21310000000 |
Tenet Healthcare Corporation operates as a broad-ranging provider of health solutions. The company organizes its operations across three main divisions: Hospital Operations and Other, Ambulatory Care, and Conifer. Within its network of acute care facilities, Tenet delivers a full spectrum of essential services. These include core hospital functions such as operating and recovery suites, radiology and respiratory…
Consensus Buy from 23 analysts. Average price target $288.00, +9.3% versus the current price. Low $265.00. High $308.00.
Insights · Dividends · Forecast · Financials · Learn
Analysts have an average 12-month price target of $288.00 for Tenet Healthcare (THC), 9.6% above the current price of $262.81. Of 23 analysts covering the stock, 19 rate it Buy or Strong Buy, 4 Hold, and 0 Sell or Strong Sell, giving a consensus of Buy.
Forecasts are third-party estimates and often wrong. They are not investment advice.
| Low | $265.00 |
|---|---|
| Average | $288.00 |
| High | $308.00 |
The average is 9.6% above the current price of $262.81.
Of 23 analysts, 19 rate Tenet Healthcare Buy or Strong Buy, 4 Hold, and 0 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.
Analyst averages on file: 2026, EPS $21.20, revenue $22.23 billion. 2027, EPS $21.07, revenue $22.51 billion.
The Stocklytics Score for THC is 53 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
$288.00 average, with a published range of $265.00 to $308.00.
The consensus is Buy from 23 analysts. This is not a recommendation.
Analysts' average EPS estimate for 2026 on file is $21.20. The average revenue estimate is $22.23 billion.
No reliable forecast exists that far out.
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Related: Tenet Healthcare · Financials · Dividends · Compare · AI stocks
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.
$21.22B
Market Cap
10.31
P/E
12.43
Forward P/E
53
Score